short bowel syndrome
play

Short Bowel Syndrome Sang-Mo Kang, M.D. Division of Transplantation - PowerPoint PPT Presentation

Disaster Short Bowel Syndrome Sang-Mo Kang, M.D. Division of Transplantation Director, Intestinal Rehabilitation and Transplantation University of California, San Francisco Short Bowel Syndrome Disaster Normal Short Bowel Feldmans


  1. Disaster Short Bowel Syndrome Sang-Mo Kang, M.D. Division of Transplantation Director, Intestinal Rehabilitation and Transplantation University of California, San Francisco Short Bowel Syndrome Disaster Normal Short Bowel Feldman’s GastroAtlas online 1

  2. Overview Intestinal Failure: Definition • Definition/Incidence of Intestinal Failure • Intestinal Physiology • A condition in which inadequate digestion and/or absorption of • Etiology and Pathophysiology nutrients leads to malnutrition and/or • Intestinal adaptation dehydration • Medical Management –rehabilitation • Inability of the native gastrointestinal • Surgical Management tract to provide nutritional autonomy • Intestinal transplantation Nightingale J, ed. Intestinal Failure. 2001 Fishbein TM et al. Gastroenterology 2003;124:615 Incidence and Prevalence Causes of Intestinal Failure: Major Categories • 3-4/million in western countries eventually develop intestinal failure • Occurs in ~ 15% of pts undergoing intestinal resection • Loss of bowel length – ¾ occur from massive resection – ¼ from multiple sequential resections • Loss or absence of bowel • ~70 % pts with SBS are d/c from the hospital & ~ 70% of these function remain alive one year later • Improved Survival is due to ability to deliver long-term nutritional • Unresectable tumors support DiBaise JK et al. Am Gastro 2004; 99: 1386-95 Thompson JS. J Gastrointestinal Surg 2000; 4 :101-4. Messing B. et al Gastroenterology 1999; 117:1043-50 2

  3. Pathophysiology Short Bowel Syndrome (SBS) INTESTINAL REMNANT LENGTH is the primary • determinant of outcome but quality also important • Defined as loss of � 2/3 of small bowel • Resection of up to ½ of the SB is usually well tolerated (remnant of <200 cm) • SBS is most likely to develop in patients losing > 2/3 length of SB. Wilmore DW, Best Pract Res Clin Gastroenterol 2003;17:895 • Adults likely to require long-term TPN: – <50 cm small bowel AND colon • “Functional” definition? (Fecal energy – <100 cm small bowel AND NO colon loss) • Children likely to require long-term TPN: – <30 cm small bowel • Most common condition resulting in • Presence of ileocecal valve is highly advantageous – Due to presence of ileum, prevention of bacterial reflux intestinal failure Carbonnel F et al JPEN 1996;20:275-80. DiBaise JK et al., Am J Gastroenterol 2004;99:1386 Normal Intestinal Function Intestinal Growth �������������������������������� • Small intestine ��� – Greatest growth velocity during ��� last trimester ���������� � ��� – Term ~275cm ��� • Colon ��� – 30-40cm at birth ��� � � �� �� – 1.5-2.0m in adult ��������� Feldman’s GastroAtlas online Weaver LT et al Gut 1991;32:1321-3 3

  4. Stages Following Massive Resection Intestinal Adaptation • Muscular hypertropy • Large fluid/electrolyte losses (weeks) – Increased bowel diameter – Increased wall thickness • Fewer fluid and electrolyte problems; need for nutritional support (months/year) • Mucosal hyperplasia – TPN weaning? – Crypt cell proliferation – Increased number of enterocytes • Intestinal adaptation – Villous hyperplasia • Lengthening DiBaise JK et al. , Am J Gastroenterol 2004;99:1386 Sacks AI et al J Pediatr Gastroenterol Nutr 1995;21:158-64 �������������������������������� Intestinal Adaptation • Hormonal mediators • Dependent on enteral nutrients – Growth hormone • May take 1-2 years – Glucagon like peptides – Enteroglucagon – Neurotensin • Ileum adapts for macronutrient absorption – Peptide YY – Insulin-like growth factor • Blunted adaptation: Active Crohn’s, pubs.acs.org radiation enteritis, carcinoma, • Luminal factors pseudoobstruction – Glutamine – Polyamines – Epidermal growth factor – Trefoil peptides – Short chain fatty acids DiBaise JK et al. , Am J Gastroenterol 2004;99:1386 – Long chain fatty acids Buchman AL et al. Gastroenterology 2003;124:1111 4

  5. SBS: Medical Management Medical Management • Fluid and electrolytes • Early management: Critically ill in post-op setting – Oral rehydration solution – Control of sepsis, maintenance of fluid and electrolyte balance – Antisecretory agents (PPI) – TPN is required early – Antimotility agents – Initiation of enteral feeds when possible • Lomotil, Imodium, tincture of opium – Fluid and electrolytes losses are high in post-op period management can be challenging – Supplemental IV fluids may be required in addition to TPN • For pts that survive the early phase, goals are to maintain adequate nutritional status and prevent complications • Micronutrients MAINTENANCE OF NUTRITIONAL STATUS • BECOMES THE PRIMARY GOAL ���������������������� Medical Management -Dietary Management- • Gastric acid hypersecretion • Pts should eat more than usual (hyperphagic) • Metabolic bone disease • Small meals throughout the day and/or tube feeds • Calcium deficiency • Pts with colonic continuity should eat complex CHO • Renal calculi with starch, non-starch polysaccharides and • Hyperoxaluria soluble fibers (not absorbed by SB). • Liver disease – Colon ferments these carbs � butyrate (fuel) • Cholelithiasis – 500-1000 Kcals can be absorbed from colocytes • Bacterial overgrowth – Amount of energy absorbed is proportional to the • D-lactic acidosis length of the residual colon and may increase with • Neurologic syndrome adaptive response to resection – Medium chain triglycerides can be absorbed in the colon 5

  6. Glucagon like peptide 2 SBS: Pharmacologic Options • Proglucagon-derived peptides – Synthesized in L cells • Antisecretory, antimotility agents • Tissue specific post-translational processing of proglucagon in the intestine liberates PGDPs • Antibiotics for overgrowth • Growth hormone? • Glucagon-like peptide II (Gattex) • Glutamine supplementation of feeds • Highly localized expression of GLP-2 receptor in intestinal epithelium Glucagon like peptide 2 Teduglutide (Gattex) • Secreted in response to food ingestion • Promotes nutrient absorption by expansion of the mucosal epithelium • Stimulates crypt cell proliferation • Inhibitory effects on motility and secretion • Post-prandial GLP-2 secretion is impaired in patients without a terminal ileum or colon Jeppesen et al Gut. 2011;60:902-14 6

  7. How to feed • CONTINUOUS ENTERAL FEEDINGS ARE ADVANTAGEOUS – Via NG or GT – Constant saturation of carrier transport proteins – Take full advantage of absorptive surface area available • Older children have better capacity to regulate gastric emptying Jeppesen et al Gut. 2011;60:902-14 How to feed Home Parental Nutrition • TPN should be compressed volume and time • ADVANCE SLOWLY of infusion. (preferably over night) – Concentration vs. volume • Tapered over 30-60 min to avoid • Small quantities of oral feedings hypoglycemia. – Scheduled at least 2-3 times per day • Complications; – Stimulate suck swallow – Avoid line sepsis (0.3/ year) – Minimize feeding aversion – Line thrombosis Woolf GM et al Gastroenterolgy 1983; 84;823-8 7

  8. PNALD PN complications • Biochemical elevations in: – Serum aminotransferases – Alkaline phosphatase, GGT • Catheter related: • Metabolic: – Bilirubin – Liver disease • Histologic changes – Sepsis – Biliary stones – Steatosis – Access – Metabolic bone – Steatohepatitis disease – Venous thrombosis – Cholestasis – Trace element – Occlusion – Cirrhosis and/or vitamin – Migration deficiency • May improve with decreased lipid infusion and/or switch to Omega-3 enriched lipids SBS: Surgical Management Surgical Management • Ostomy closure • Dilated segments of bowel with ineffective • Restoration of bowel continuity peristalsis are associated with: • Bowel lengthening and tapering – bacterial overgrowth – secretory diarrhea procedures – mucosal inflammation – increased malabsorption – increase risk of liver disease • Aims: – Increase total length of small bowel, prevent stasis in dilated segment 8

  9. Increasing Absorptive Surface Area Surgical Management Bianchi Procedure • Experimental animal models: – Contruction of intestinal valve or sphincter – Denervation of intestinal segments • Human Experience: – Reversing segments of intestine • Antiperistaltic “physiologic valve” – Bowel lengthening procedures: • Bianchi – longitutinal lengthening • STEP – serial transverse enteroplasty Bianchi A. J Ped Surg 1980;15:145 Increasing Absorptive Surface Area Serial Transverse Enteroplasty (STEP) • Pt selection- Dilated intestinal segment, bacterial overgrowth. • Stapler is from Alternating directions. • Less complicated than Bianchi Procedure. • Improves absorptive capacity in ~ 90% pts. • Complications: – Leak and obstruction ~20% Kim H et al. J Ped Surg 2003;38:425 9

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend